CHMP opinions on consultation procedures
The European Medicines Agency (EMA) publishes a consultation procedure public assessment report (CPAR) on the opinions prepared by its Committee for Medicinal Products for Human Use (CHMP) following a consultation procedure with EMA on the quality, safety, benefits and risks of ancillary substances incorporated in a medical device.
EMA publishes the CPAR after the notified body confirms the granting of a Conformité Européenne (CE) mark for the device.
The Agency also publishes information on procedural steps taken after a consultation procedure.
For more information on the consultation procedure, see Ancillary medicinal substances in medical devices.
CHMP opinions
Name of medical device | Vitrolife IVF media |
---|---|
Ancillary substance | Recombinant human albumin solution |
Manufacturer | Albumedix Ltd |
Notified body | DNV Product Assurance AS |
CHMP opinion |
|
Date of opinion | 25/01/2018 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
|
Name of medical device | CooperSurgical Inc ART Media |
---|---|
Ancillary substance | Human albumin |
Manufacturer | Cooper Surgical Inc |
Notified body | BSI Group The Netherlands B.V. |
CHMP opinion |
|
Date of opinion | 19/02/2011 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
|
Name of medical device | COOK IVF cell culture media |
---|---|
Ancillary substance | Human albumin solution |
Manufacturer | Catalent Indiana LLC |
Notified body | DNV GL Nemko Presafe AS |
CHMP opinion |
|
Date of opinion | 16/02/2012 |
Active review time (days) | 180 |
Steps after consultation (last updated) |
|
Name of medical device | FertiPro N.V. HSA-containing ART media |
---|---|
Ancillary substance | Human albumin solution |
Manufacturer | FertiPro N.V. |
Notified body | BSI Group The Netherlands B.V. |
CHMP opinion |
|
Date of opinion | 19/01/2012 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
|
Name of medical device | Floseal haemostatic matrix (Floseal VH S/D) |
---|---|
Ancillary substance | Human thrombin |
Manufacturer | Baxter AG |
Notified body | TÜV SÜD Product Service GmbH |
CHMP opinion |
|
Date of opinion | 19/02/2009 |
Active review time (days) | 204 |
Steps after consultation (last updated) |
|
Name of medical device | Gems Medium Suite |
---|---|
Ancillary substance | Human serum albumin |
Manufacturer | Genea Biomedx PTY Limited |
Notified body | BSI Group The Netherlands B.V. |
CHMP opinion |
|
Date of opinion | 23/04/2015 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
|
Name of medical device | Hemoblast Bellows |
---|---|
Ancillary substance | Human thrombin |
Manufacturer | Biom'Up France SAS |
Notified body | BSI Group The Netherlands B.V. |
CHMP opinion |
|
Date of opinion | 25/09/2014 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
|
Name of medical device | Irvine Scientific Reproductive Media |
---|---|
Ancillary substance | Human albumin |
Manufacturer | Irvine Scientific |
Notified body | National Standards Authority of Ireland (NSAI) |
CHMP opinion |
|
Date of opinion | 21/02/2008 |
Active review time (days) | 176 |
Steps after consultation (last updated) |
|
Name of medical device | IVF Media G5 |
---|---|
Ancillary substance | Human albumin |
Manufacturer | Vitrolife Sweden AB |
Notified body | Det Norske Veritas Certification AS |
CHMP opinion |
|
Date of opinion | 28/06/2006 |
Active review time (days) | 174 |
Steps after consultation (last updated) |
|
Name of medical device | LifeGlobal Media |
---|---|
Ancillary substance | Human serum albumin |
Manufacturer | Life Global Group LLC |
Notified body | BSI Group The Netherlands B.V. |
CHMP opinion |
|
Date of opinion | 26/01/2017 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
|
Name of medical device | Origio |
---|---|
Ancillary substance | Human albumin |
Manufacturer | Origio a/s |
Notified body | Presafe Denmark A/S |
CHMP opinion |
|
Date of opinion | 14/12/2007 |
Active review time (days) | 195 |
Steps after consultation (last updated) |
|
Name of medical device | Origio A.R.T. Media |
---|---|
Ancillary substance | Gentamicin sulfate / sargramostim (GM-CSF) / heparin sodium / insulin human |
Manufacturer | Origio a/s |
Notified body | BSI Group, The Netherlands |
CHMP opinion |
|
Date of opinion | 20/07/2023 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
Name of medical device | PureSperm Wash |
---|---|
Ancillary substance | Human albumin solution |
Manufacturer | NidaCon International AB |
Notified body | Det Norske Veritas Certification AS |
CHMP opinion |
|
Date of opinion | 21/02/2013 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
Name of medical device | Surgiflo haemostatic matrix kit - Ferrosan |
---|---|
Ancillary substance | Human thrombin |
Manufacturer | Ferrosan A/S |
Notified body | Presafe Denmark A/S |
CHMP opinion |
|
Date of opinion | 19/05/2011 |
Active review time (days) | 210 |
Steps after consultation (last updated) |
|
Name of medical device | Steen solution |
---|---|
Ancillary substance | Human albumin |
Manufacturer | XVIVO Perfusion AB |
Notified body | Det Norske Veritas Certification AS |
CHMP opinion |
|
Date of opinion | 13/10/2005 |
Active review time (days) | 180 |
Steps after consultation (last updated) |
|